News & Events
December 21, 2011: GlobalStem establishes LIFE TECHNOLOGIES (INDIA) PVT. LTD as their distributor in India . Including distribution in South Asia and Middle East.
November 9, 2011: GlobalStem launches a new website, featuring expanded product information and a new streamlined user experience. Our new website is just another important step in our growing business.
September 5, 2011: GlobalStem launches GeneIn™, a novel transfection reagent for hard-to-transfect cell lines. GeneIn™ is the first new product from a proprietary transfection chemistry platform developed at MTI-GlobalStem (patent pending).
May 1, 2011: GlobalStem doubles its manufacturing facility to meet the growth of our product sales over the last several years. To meet this growing demand of our customers we have finished construction of our expanded manufacturing lab space.
November 15, 2009: Molecular Transfer, Inc. acquires GlobalStem. View press release. Molecular Transfer, Inc. today announced that it has acquired Globalstem, a provider of stem cell reagents and services. This acquisition will allow MTI to move quickly into the stem cell market using Globastem’s strong market presences and experienced stem cell and neuroscience scientific team.
February 25, 2009: Rockville, MD and Princeton, NJ - CHDI Foundation has entered an agreement with GlobalStem to comprehensively expand, authenticate and bank mouse embryonic stem (ES) cell lines that model Huntington's disease, a hereditary neurodegenerative disorder. GlobalStem expertise will be tapped to provide full characterization of the cells including sterility and Mycoplasma detection testing, karyotyping and assaying for critical markers.
November 12, 2007: GlobalStem is awarded two Phase 1 SBIR grants by the U.S. National Institutes of Health (NIH). The first grant titled, "Propagation and Characterization of two Mouse Embryonic Stem Cell Lines," will affiliate GlobalStem with a trans-NIH initiative called the Knockout Mouse Project (KOMP) and will make scientifically valuable mouse embryonic stem (ES) cell lines available for research. The second grant titled, "Engineering a non-selective microenvironment for human embryonic stem cells (hESC)," will allow GlobalStem to create genetically modified human feeder cells for the support of undifferentiated hESC.